Moderna Officer Shannon Klinger Files Form 144 for $485.8K Proposed Sale
Moderna, Inc.
Subscribe to track MRNA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Moderna, Inc. ($MRNA) — Form 144 Notice of Proposed Sale • Insider: Shannon Thyme Klinger (Officer) • Shares to Sell: 3,471 Common Shares • Estimated Value: $485,766.45 (~$139.95/share) • Broker: Fidelity Brokerage Services LLC • Acquisition Source: Stock Option Exercise on 09/01/2026 • Trading Plan: Rule 10b5-1 plan adopted on 09/09/2025
Comprehensive Analysis
Executive Summary
On September 1, 2026, Shannon Thyme Klinger, an Officer of Moderna, Inc. ($MRNA), filed a Form 144 notice of proposed sale covering 3,471 shares of common stock with an aggregate market value of $485,766.45.
Transaction & Acquisition Details
- Proposed Sale Date: September 1, 2026
- Number of Shares: 3,471 common shares
- Aggregate Market Value: $485,766.45 (approx. $139.95 per share)
- Acquisition Nature: Acquired via cash exercise of stock options from the issuer on September 1, 2026.
- Pre-set Trading Plan: Executed pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025.
Prior 3-Month Activity
- June 4, 2026: Sold 3,471 shares for gross proceeds of $173,550.00.
Market Significance
This filing represents a routine option exercise and liquidation under a pre-established Rule 10b5-1 plan. Given the standard size and planned nature of the transaction, the market significance is considered Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.